RTN4IP1 and esophageal squamous cell carcinoma: Further investigations into RTN4IP1 will be instrumental in unveiling its detailed biochemical function and developing specific inhibitors of RTN4IP1, which may be promising options to overcome the limitations of ESCC therapy.